Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
61 | nsp5AB:K61-; | CL-3e; |
88 | nsp5AB:K88N; | CL-3b;CL-3e; |
97 | nsp5AB:K97N; | CL-3f; |
141 | nsp5AB:L141-; | CL-3b; |
167 | nsp5AB:L167-; | CL-3d;CL-3e; |
167 | nsp5AB:L167I; | CL-3e; |
227 | nsp5AB:L227-; | CL-3e;CL-3f; |
227 | nsp5AB:L227I; | CL-3e; |
232 | nsp5AB:L232-; | CL-3e; |
232 | nsp5AB:L232I; | CL-1a_3f;CL-3e; |
242 | nsp5AB:L242-; | CL-3f; |
250 | nsp5AB:L250-; | CL-3b;CL-3e; |
250 | nsp5AB:L250I; | CL-3e; |
253 | nsp5AB:L253F; | CL-3f; |
271 | nsp5AB:L271-; | CL-3b;CL-3e; |
272 | nsp5AB:L272-; | CL-3f; |
282 | nsp5AB:L282F; | CL-3e; |
286 | nsp5AB:L286-; | CL-3b; |
32 | nsp5AB:L32-; | CL-3e; |
50 | nsp5AB:L50-; | CL-3d;CL-3e; |
50 | nsp5AB:L50V; | CL-3e; |
58 | nsp5AB:L58-; | CL-3e; |
67 | nsp5AB:L67S; | CL-3c;CL-3e; |
75 | nsp5AB:L75R; | CL-3e; |
87 | nsp5AB:L87F; | CL-3b;CL-3c; |
89 | nsp5AB:L89-; | CL-3b;CL-3e; |
130 | nsp5AB:M130I; | CL-3b;CL-3d; |
162 | nsp5AB:M162-; | CL-3e;CL-3f; |
162 | nsp5AB:M162I; | CL-1a_3d;CL-1a_3e;CL-1b;CL-3c;CL-3e; |
165 | nsp5AB:M165I; | CL-3e; |
17 | nsp5AB:M17-; | CL-3e; |
17 | nsp5AB:M17T; | CL-3d; |
235 | nsp5AB:M235-; | CL-3d;CL-3e; |
264 | nsp5AB:M264V; | CL-2;CL-3e; |
276 | nsp5AB:M276-; | CL-3f; |
276 | nsp5AB:M276I; | CL-1a_3e;CL-3b;CL-3d;CL-3e; |
276 | nsp5AB:M276L; | CL-3e; |
49 | nsp5AB:M49-; | CL-1b;CL-3e;CL-3f; |
49 | nsp5AB:M49T; | CL-3b;CL-3c; |
6 | nsp5AB:M6-; | CL-3b; |
6 | nsp5AB:M6I; | CL-3b;CL-3c;CL-3e;CL-3f; |
6 | nsp5AB:M6L; | CL-3f;CL-5; |
82 | nsp5AB:M82-; | CL-3b;CL-3d; |
82 | nsp5AB:M82I; | CL-3b;CL-3e;CL-3f; |
142 | nsp5AB:N142L; | CL-3a;CL-3c; |
142 | nsp5AB:N142S; | CL-3b;CL-3e;CL-3f; |
151 | nsp5AB:N151D; | CL-3e; |
151 | nsp5AB:N151S; | CL-3c; |
228 | nsp5AB:N228S; | CL-3c;CL-3e; |
238 | nsp5AB:N238D; | CL-3b; |
Page 325 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com